A carregar...
Clobazam add‐on therapy for drug‐resistant epilepsy
BACKGROUND: Epilepsy affects approximately 1% of the population, with up to 30% of patients continuing to have seizures, despite antiepileptic drug treatment. Clobazam is a 1,5‐benzodiazepine and is commonly used as an add‐on treatment for drug‐resistant epilepsy. This review is an updated version o...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2019
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6804215/ https://ncbi.nlm.nih.gov/pubmed/31638272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004154.pub5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|